Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
Daskalakis, M.; Feller, A.; Noetzli, J.; Bonadies, N.; Arndt, V.; Baerlocher, G.M.; The NICER Working Group+.
Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017. Cancers 2021; 13: 6269.
[+ Le RNJT est membre du NICER Working Group].
